Corrigendum to "Suppression of Dynamical Network Biomarker Signals at the Predisease State (

Journal

Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021

Informations de publication

Date de publication:
2021
Historique:
received: 17 04 2021
accepted: 17 04 2021
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 14 5 2021
Statut: epublish

Résumé

[This corrects the article DOI: 10.1155/2020/9129134.].

Identifiants

DOI: 10.1155/2021/9760307 PMID: 33981354 PMC: PMC8088371
pubmed: 33981354
doi: 10.1155/2021/9760307
pmc: PMC8088371
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

9760307

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2021 Keiichi Koizumi et al.

Références

Sci Rep. 2019 Jun 24;9(1):8767
pubmed: 31235708
Evid Based Complement Alternat Med. 2020 Aug 4;2020:9129134
pubmed: 32831883

Auteurs

Keiichi Koizumi (K)

Division of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Laboratory of Drug Discovery and Development for Pre-disease, Section of Host Defences, Division of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
ORCID: 0000-0002-0349-4144

Makito Oku (M)

Division of Chemo-Bioinformatics, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Laboratory of Chemo-Bioinformatics, Section of Host Defences, Division of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
ORCID: 0000-0002-0282-2361

Shusaku Hayashi (S)

Division of Gastrointestinal Pathophysiology, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Laboratory of Gastrointestinal Disorder, Section of Host Defences, Division of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
ORCID: 0000-0002-8304-7255

Akiko Inujima (A)

Division of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Laboratory of Drug Discovery and Development for Pre-disease, Section of Host Defences, Division of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
ORCID: 0000-0003-0430-8419

Naotoshi Shibahara (N)

Division of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
ORCID: 0000-0003-4361-8006

Luonan Chen (L)

CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.
ORCID: 0000-0002-3960-0068

Yoshiko Igarashi (Y)

First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
ORCID: 0000-0003-4627-1394

Kazuyuki Tobe (K)

First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
ORCID: 0000-0003-0015-0255

Shigeru Saito (S)

University of Toyama, Toyama, Japan.
ORCID: 0000-0002-8940-3708

Makoto Kadowaki (M)

Division of Gastrointestinal Pathophysiology, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
ORCID: 0000-0002-5945-9380

Kazuyuki Aihara (K)

Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.
International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo Institutes for Preemptive Study, The University of Tokyo, Tokyo, Japan.
ORCID: 0000-0002-4602-9816

Classifications MeSH